Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

Bio2RDF uri

Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

http://bio2rdf.org/clinicaltrials:NCT01708798

Bio2RDF identifier

NCT01708798

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01708798

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

Doxorubicin and other a ...... er doxorubicin therapy.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Study of the Effect of Epleren ...... Chemotherapy for Breast Cancer

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:other outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:other-outcome]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:08fc6a1f9a680a2d595f7519fee0f630]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:3f40f15bca6fde6201645961a60b2cb7]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:45fbda77fc4014cfe020903b15ce00e8]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:498ab4f83da0cd2f0291d150e354028f]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:8409b905930fb2df82c20c4d228bddb6]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:b48664c82c5fcd19499e01f9b2ae7c31]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:ee71cdb48a7bebdd7f9e3a15c29abe51]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:8855649188dbf12474fce14c6bf786e6]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:1ba8935c9a2c58a8817ea2f8f5e9c75e]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:2d0e1e0cd91a99fd657318030334347b]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:31dd9b3a2aceb75c1e5bc7fa4bb61b48]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:3c45999bab7c95e4a07cb3bcf683fab8]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:67da5a77c13f559c068f65ee3ef45fe3]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:8bfb6e1f72de3bcd5d48729d59521cff]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:8e5b56e3d97e02735a679fe30720621c]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:9d02c647788daffe167a54f2699528ff]

Change in average E' (averaged septal E' and lateral E') 6 months [clinicaltrials_resource:f08b32dd363bf1169ffb4588295e95b0]

collaborator [clinicaltrials_vocabulary:collaborator]

University of British Columbia [clinicaltrials_resource:8b55d23cf0513a9c7f613491b508c528]

completion date [clinicaltrials_vocabulary:completion-date]

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Breast Cancer [clinicaltrials_resource:a6e49f6d743530e757454793a1cbf363]

condition browse [clinicaltrials_vocabulary:condition-browse]

Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Breast Neoplasms [clinicaltrials_resource:fd46a662c92164802f60e654a768351f]

country [clinicaltrials_vocabulary:country]

Canada [clinicaltrials_resource:445d337b5cd5de476f99333df6b0c2a7]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01708798 [clinicaltrials_resource:fb4cc06a64a4ed2b615031e0f6a18d68]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2012-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Eplerenone [clinicaltrials_resource:af98227abc6627c37f1c216fb7cde105]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Eplerenone [clinicaltrials_resource:f5dfbeea6e8063918503c1a21cbe024b]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Diastolic heart failure

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

University of British Columbia [clinicaltrials_resource:8b55d23cf0513a9c7f613491b508c528]

location [clinicaltrials_vocabulary:location]

British Columbia Cancer Agency, Vancouver Centre [clinicaltrials_resource:5b61c8e3abd6bc487d2d15ecf1953490]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01708798

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Prospective Randomized Place ...... line Therapy for Breast Cancer

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

H12-00185

http://www.w3.org/2001/XMLSchema#string

overall contact [clinicaltrials_vocabulary:overall-contact]

Sean A Virani, MD, MSc, MPH [clinicaltrials_resource:f9195a6382160568c7dd94de61b446fa]

overall contact backup [clinicaltrials_vocabulary:overall-contact-backup]

Sean A Virani, MD, MSc, MPH [clinicaltrials_resource:9af769b5f7daab167ee1e98804ff91b0]

overall official [clinicaltrials_vocabulary:overall-official]

Sean A Virani, MD, MSc, MPH [clinicaltrials_resource:2644562787c572e60a1a62b04c13912c]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

Canada: Health Canada [clinicaltrials_resource:18d676c41d7569f90bb05a57eff2a0c0]

phase [clinicaltrials_vocabulary:phase]

Phase 2/Phase 3 [clinicaltrials_resource:d4235ce98efbb8b69dded131ccb7fa52]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

11094035 [pubmed:11094035]

11153752 [pubmed:11153752]

11711528 [pubmed:11711528]

11870163 [pubmed:11870163]

12075737 [pubmed:12075737]

12668699 [pubmed:12668699]

15277317 [pubmed:15277317]

15941672 [pubmed:15941672]

16043662 [pubmed:16043662]

16213474 [pubmed:16213474]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

University of British Columbia [clinicaltrials_resource:8b55d23cf0513a9c7f613491b508c528]

start date [clinicaltrials_vocabulary:start-date]

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01708798 study design [clinicaltrials_resource:7050e57295659e02c9623d8a0972dd2d]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01708798

verification date [clinicaltrials_vocabulary:verification-date]

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01708798

http://www.w3.org/2001/XMLSchema#string

title

Study of the Effect of Epleren ...... Chemotherapy for Breast Cancer

@en